Chiral polymer nanoparticles for probing biological systems
Chiral polymer nanoparticles for probing biological systems
批准号:
9396956
负责人:
Nathan John Oldenhuis
金额:
$5.63万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-01 至 2020-08-31
关键词:
AdoptionAdverse effectsAffectAmino AcidsArginineBiodistributionBiologicalBlood CirculationCellsChargeClinicClinicalComplexConfocal MicroscopyCrosslinkerDegenerative DisorderDevelopmentDiseaseDisease modelDoseDrug Delivery SystemsDrug KineticsEndocytosis PathwayErythrocytesExposure toExtravasationFluorescence MicroscopyGlutamic AcidGrowthHalf-LifeHereditary DiseaseHistologicIn VitroInbred BALB C MiceIncubatedKilogramKineticsLabelLaboratoriesLettersLiteratureMalignant NeoplasmsMass Spectrum AnalysisMaximum Tolerated DoseMeasuresMethodsModelingMolecularMolecular StructureMusPathway interactionsPenetrationPeptidesPlasmaPlasma ProteinsPolyethylene GlycolsPolymersProductionPropertyProteinsProteomicsReportingReproducibilityResearchResearch ContractsSeriesSerineShapesStructureSurfaceSystemTechniquesTechnologyTherapeuticTherapeutic AgentsTherapeutic UsesTimeTissue SampleTissuesToxic effectTranslatingTranslationsadvanced systemarmbasebiological systemscytotoxicitydesignimmunogenicityin vivoinsightinterestnanomedicinenanoparticlenovelnovel strategiespolymerizationpreclinical trialresponsescaffoldsubcutaneoustumoruptakezeta potential
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract:
Drug delivery represents a platform of tremendous potential in the field of nanomedicine. Delivery of
therapeutic agents directly to target cells can drastically reduce the doses required for treatment and eliminate
unwanted side effects and delivery to off-target tissues. To fully realize the potential of nanomedicince, safe,
general, and efficient drug delivery nanoparticles must be developed which can be produced at relevant scales
for study. Recently, the Johnson lab has developed a brush-arm star polymer (BASP) system that can
successfully deliver a wide variety of different therapeutic agents in controllable ratios both in vivo and in vitro.
Additionally, BASPs can be produced readily on kilogram scales, and are being currently evaluated in preclinical
trials in mice. In this proposal, we aim to create a series of novel BASPs with controllable functionality to alter
the pharmacokinetic properties for targeting new diseases and tissues for delivery. Using a new iterative peptide
polymer (IPP) synthesis technique, we will be able to construct IPP appended BASPs that will allow for complete
control over size, charge, chirality, and produce them at scales relevant for therapeutic applications. After
synthesis of the BASPs we will extensively study their pharmacokinetic properties. By studying protein corona
composition, uptake pathways, uptake kinetics, toxicity, immunogenicity, biodistribution and biological half-life
we hope to derive structure-property relationships to develop BASPs that can target a variety of tissues via
different mechanisms. There is a high demand to study drugless carriers to better understand their base
properties before therapeutic use or use in disease models. Because the BASPs can be loaded with a variety of
therapeutic agents (which do not alter its properties), we hope to ultimately develop a technology platform where
different BASPs could be used to deliver any therapeutic agent to any tissue of interest in a controlled matter in
response to this demand. Establishing the groundwork for these systems will hopefully create successful
treatments for many diseases, and serve as a base for the development of even more advanced systems.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chiral polymer nanoparticles for probing biological systems
-
批准号:9765337
-
项目类别:
-
资助金额:$6.03万
-
财政年份:2017
-
负责人:Nathan John Oldenhuis
-
依托单位:
Saccharide Functionalization of Bola-amphiphiles for siRNA Delivery
-
批准号:8981788
-
项目类别:
-
资助金额:$3.73万
-
财政年份:2015
-
负责人:Nathan John Oldenhuis
-
依托单位:
海外基金